Skip to content

XYL

by Biomerieux SA

Ref 541070

XYL is an in vitro diagnostic device (EU IVDR Class B; FDA Class I; FDA product code JTO, Discs, Strips and Reagents, Microorganism Differentiation; EMDN category manual susceptibility testing) made by Biomerieux SA, registered in EUDAMED on 26 May 2026 (Basic UDI-DI 357302BUDI000283TJ) and listed in FDA GUDID since 10 Apr 2020 (UDI-DI 03573026588748), active as of 12 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number357302BUDI000283TJ Basic UDI-DI 03573026588748UDI-DIDate26 May 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number03573026588748 UDI-DI Date10 Apr 2020ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
XYL is a reagent associated to API 20 A® (20 300)
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 12 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 357302BUDI000283TJ registered 26 May 2026 Active
  • FDA GUDID UDI-DI 03573026588748 listed 10 Apr 2020 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 03573026588748
  2. Registered EUDAMED 357302BUDI000283TJ

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Generic name
Multiple anaerobic bacteria species culture isolate identification IVD, reagent
Model / reference
541070 EUDAMED
XYL GUDID
Primary DI / UDI-DI
03573026588748
Basic UDI-DI
357302BUDI000283TJ
FDA product code
JTO
EMDN code
W0104080599 Manual susceptibility testing - other
GMDN term
Multiple anaerobic bacteria species culture isolate identification IVD, reagent
Device class
Class B EUDAMED
Class I GUDID
Regulation number
866.2660
EU registration type
Standard device
EU market of registration
France
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
541070
GUDID
XYL
Device classEUDAMED
Class B
GUDID
Class I

Device class is stated on each registry's own scale: Class B in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under MANUAL SUSCEPTIBILITY TESTING.

Other devices from Biomerieux SA

See all devices from Biomerieux SA →

Properties

  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)